AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,000 | -15.4% | 2,211 | -11.3% | 0.00% | – |
| Q4 2020 | $13,000 | +8.3% | 2,493 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -25.0% | 2,493 | -23.4% | 0.00% | – |
| Q2 2020 | $16,000 | +77.8% | 3,253 | +58.7% | 0.00% | – |
| Q2 2019 | $9,000 | -35.7% | 2,050 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | +180.0% | 2,050 | +153.1% | 0.00% | – |
| Q4 2018 | $5,000 | -64.3% | 810 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | – | 810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |